Bevacizumab in the treatment of ovarian cancer
Ramez N Eskander1, Leslie M Randall21Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California Irvine Medical Center, Orange, CA, USA; 2Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine, Orange, CA, U...
Guardado en:
Autores principales: | Ramez N Eskander, Leslie M Randall |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eaf2adb7d17f4ca08eb11d5ecfccd55d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bevacizumab in the treatment of HER2-negative breast cancer
por: Vito Lorusso
Publicado: (2008) -
Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers
por: Jia Li, et al.
Publicado: (2009) -
Bevacizumab in the therapy for refractory metastatic colorectal cancer
por: Mary F Mulcahy
Publicado: (2008) -
Clinical utility of targeted treatments in the management of epithelial ovarian cancer
por: Twu C, et al.
Publicado: (2012) -
Ovarian cancer: emerging molecular-targeted therapies
por: Sourbier C
Publicado: (2012)